CRS
Overvalued by 101% based on the discounted cash flow analysis.
Market cap | $4.96 Billion |
---|---|
Enterprise Value | $5.60 Billion |
Dividend Yield | $0.7966 (0.8%) |
Earnings per Share | $2.88 |
Beta | 1.21 |
Outstanding Shares | 49,608,268 |
Avg 30 Day Volume | 733,098 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 34.58 |
---|---|
PEG | -52.02 |
Price to Sales | 1.85 |
Price to Book Ratio | 3.33 |
Enterprise Value to Revenue | 2.06 |
Enterprise Value to EBIT | 19.19 |
Enterprise Value to Net Income | 42 |
Total Debt to Enterprise | 0.12 |
Debt to Equity | 0.46 |
No data
No data